729 related articles for article (PubMed ID: 26379095)
1. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
[TBL] [Abstract][Full Text] [Related]
4. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
[TBL] [Abstract][Full Text] [Related]
5. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR
N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
[TBL] [Abstract][Full Text] [Related]
7. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
Wadwa RP; Reed ZW; Buckingham BA; DeBoer MD; Ekhlaspour L; Forlenza GP; Schoelwer M; Lum J; Kollman C; Beck RW; Breton MD;
N Engl J Med; 2023 Mar; 388(11):991-1001. PubMed ID: 36920756
[TBL] [Abstract][Full Text] [Related]
8. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
9. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
[TBL] [Abstract][Full Text] [Related]
11. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
Lee TTM; Collett C; Bergford S; Hartnell S; Scott EM; Lindsay RS; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Reynolds RM; Flanagan E; Hammond M; Shepstone L; Wilinska ME; Sibayan J; Kollman C; Beck R; Hovorka R; Murphy HR;
N Engl J Med; 2023 Oct; 389(17):1566-1578. PubMed ID: 37796241
[TBL] [Abstract][Full Text] [Related]
12. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Bally L; Thabit H; Kojzar H; Mader JK; Qerimi-Hyseni J; Hartnell S; Tauschmann M; Allen JM; Wilinska ME; Pieber TR; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2017 Apr; 5(4):261-270. PubMed ID: 28094136
[TBL] [Abstract][Full Text] [Related]
13. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
[TBL] [Abstract][Full Text] [Related]
14. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.
Thabit H; Lubina-Solomon A; Stadler M; Leelarathna L; Walkinshaw E; Pernet A; Allen JM; Iqbal A; Choudhary P; Kumareswaran K; Nodale M; Nisbet C; Wilinska ME; Barnard KD; Dunger DB; Heller SR; Amiel SA; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2014 Sep; 2(9):701-9. PubMed ID: 24943065
[TBL] [Abstract][Full Text] [Related]
15. Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
Tauschmann M; Allen JM; Wilinska ME; Thabit H; Stewart Z; Cheng P; Kollman C; Acerini CL; Dunger DB; Hovorka R
Diabetes Care; 2016 Jul; 39(7):1168-74. PubMed ID: 26740634
[TBL] [Abstract][Full Text] [Related]
16. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.
Tauschmann M; Allen JM; Wilinska ME; Thabit H; Acerini CL; Dunger DB; Hovorka R
Diabetes Care; 2016 Nov; 39(11):2019-2025. PubMed ID: 27612500
[TBL] [Abstract][Full Text] [Related]
17. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
[TBL] [Abstract][Full Text] [Related]
18. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.
Hovorka R; Elleri D; Thabit H; Allen JM; Leelarathna L; El-Khairi R; Kumareswaran K; Caldwell K; Calhoun P; Kollman C; Murphy HR; Acerini CL; Wilinska ME; Nodale M; Dunger DB
Diabetes Care; 2014; 37(5):1204-11. PubMed ID: 24757227
[TBL] [Abstract][Full Text] [Related]
19. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
[TBL] [Abstract][Full Text] [Related]
20. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
